Molina Healthcare Q3 2026 earnings beat estimates but EPS falls 53% as guidance reaffirmed

Molina Healthcare reported third‑quarter 2026 GAAP earnings of $0.73 per share and adjusted earnings of $0.89 per share, a drop of about 53% year‑over‑year. Total revenue was $11.08 billion, with premium revenue of roughly $10.46 billion, and the company served about 4.9 million members. The firm reaffirmed its full‑year 2026 guidance of at least $5.25 adjusted EPS and $42 billion in premium revenue.

The sharp EPS decline signals lower profitability despite beating revenue estimates, which may pressure the stock price; however, the unchanged full‑year guidance suggests management expects the current performance to be sustainable.

  • 1Q3 2026 GAAP diluted EPS was $0.73 and adjusted diluted EPS was $0.89, down about 53% YoY.
  • 2Total revenue for the quarter was $11.08 billion.
  • 3Premium revenue for the quarter was $10.46 billion.
  • 4The company served approximately 4.9 million members as of September 30, 2026.
  • 5Full‑year 2026 adjusted earnings per share guidance is at least $5.25.
  • 6Full‑year 2026 premium revenue guidance remains at $42 billion.

Sources